Breaking News Instant updates and real-time market news.

STZ

Constellation Brands

$150.91

-21.38 (-12.41%)

, CGC

Canopy Growth

$33.64

4.01 (13.53%)

08:39
01/10/19
01/10
08:39
01/10/19
08:39

Constellation Brands price target lowered to $235 from $260 at Wells Fargo

Wells Fargo analyst Bonnie Herzog lowered her price target for Constellation Brands (STZ) to $235 from $260 following "disappointing' Q3 results and FY19 guide down. The continues to view the stock as best-in-class with huge potential upside from its cannabis investment and therefore believes the sharp selloff in the shares is "way overdone!" However, Constellation Brands' miss on beer depletions, guide down on FY19 beer OI margin, pressure on its wine biz and lack of visibility on the impact of its Canopy Growth (CGC) investment on earnings will likely "keep the bears growling near-term." Herzog reiterates an Outperform rating on Constellation Brands' shares.

STZ

Constellation Brands

$150.91

-21.38 (-12.41%)

CGC

Canopy Growth

$33.64

4.01 (13.53%)

  • 18

    Feb

STZ Constellation Brands
$150.91

-21.38 (-12.41%)

01/10/19
COWN
01/10/19
NO CHANGE
Target $220
COWN
Outperform
Constellation Brands price target lowered to $220, remains top pick at Cowen
Cowen analyst Vivien Azer lowered her price target on Constellation Brands to $220 from $260 following Q3 results. The analyst cited its guidance and wine challenges. However, she remains positive on the company given its best-in-class beer portfolio, meaningful exposure to cannabis, and a strong shareholder return outlook for the next three years. Azer reiterated her Outperform rating on Constellation Brands shares.
01/10/19
JPMS
01/10/19
NO CHANGE
Target $193
JPMS
Overweight
Constellation Brands selloff yesterday 'seems exaggerated', says JPMorgan
JPMorgan analyst Andrea Teixeira lowered her price target for Constellation Brands to $193 from $220 and keeps an Overweight rating on the shares following yesterday's Q3 earnings and upside fiscal 2019 guidance. The reduction in guidance more than offset the 5% beat in the quarter, and fueled the bear thesis that the beer business will decelerate faster than consensus already anticipates, Teixeira tells investors in a post-earnings research note. The analyst, however, thinks the stock's selloff yesterday "seems exaggerated." The lowered guidance came in mostly on the back of weaker outlook for the lower-end wine brands which are non-core, says the analyst. She believes patience will pay-off for medium to long-term investors.
01/10/19
SBSH
01/10/19
NO CHANGE
Target $168
SBSH
Neutral
Constellation Brands price target lowered to $168 from $240 at Citi
Citi analyst Wendy Nicholson lowered her price target for Constellation Brands to $168 to reflect yesterday's updated 2019 guidance. The analyst keeps a Neutral rating on the shares.
CGC Canopy Growth
$33.64

4.01 (13.53%)

01/10/19
RHCO
01/10/19
NO CHANGE
Target $165
RHCO
Hold
Constellation Brands price target lowered to $165 from $180 at SunTrust
SunTrust analyst William Chappell lowered his price target on Constellation Brands (STZ) to $165 and kept his Hold rating on the stock. The analyst cites the company's reported expectations of declining wine and spirits sales, adding that the latest $4B investment in Canopy Growth (CGC) will be the "cloud" hanging over the stock for the next few quarters because of the uncertainty related to its potential growth.
01/10/19
GSCO
01/10/19
UPGRADE
Target $211
GSCO
Buy
Constellation Brands upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Constellation Brands (STZ) to Buy while lowering her price target for the shares to $211 from $243. The stock closed yesterday down 12.5%, or $21.57, to $150.94 post the company's Q3 earnings report. Constellation is down over 30% in the past 12 months, mostly driven by multiple contraction, Hong tells investors in a research note. The analyst reduced her estimates to reflect a "softer outlook" but sees a "compelling" risk/reward at current share levels. Her model yields a $195 per share value for the core business excluding Canopy Growth (CGC) and a consolidated price target of $211, pointing to 40% upside. Beer sales growth should remain healthy and beer margins should improve in fiscal 2020 as cost headwinds are lapped, Hong contends. Further, she believes Constellation shares could outperform even if investors assign zero value to its investment in Canopy.
01/09/19
PIPR
01/09/19
INITIATION
PIPR
Overweight
Piper Jaffray rolls out bullish research coverage on Canopy Growth, Tilray
Piper Jaffray analyst Michael Lavery initiated coverage of Canopy Growth (CGC) and Tilray (TLRY) with Overweight ratings and price targets of $40 and $90, respectively. The analyst believes the global Cannabis market has the potential to reach $250B-$500B over the long term and $15B-$50B in the near term. The industry's long-term growth opportunities are significant, both from transitioning illicit trade to legal sales and from transitioning sales in health and wellness categories to cannabidiol-infused products, Lavery tells investors in a research note. The analyst expects recreational use to source from illicit trade and alcohol, medical use to source from other medical treatments, and non-psychoactive CBD-infused cannabis products to source users from food, beverage, and personal care categories. Over 25 countries have legal marijuana use today, he points out. Lavery believes federal legalization in the U.S. could potentially come in the next five years. Further, the analyst expects capital flow into the sector will likely continue.
01/09/19
PIPR
01/09/19
INITIATION
Target $40
PIPR
Overweight
Canopy Growth initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery started Canopy Growth with an Overweight rating and $40 price target. The analyst expects "strong" sales growth from the company, driven by "strong sustainable category momentum." Canopy's capacity advantages, beverage partnership, and balance sheet position it well over the near-term, Lavery tells investors in a research note. He also believes the company's clinical trials and intellectual property should add competitive advantages longer term.

TODAY'S FREE FLY STORIES

BRQS

Borqs Technologies

$4.00

(0.00%)

13:43
02/22/19
02/22
13:43
02/22/19
13:43
Hot Stocks
Breaking Hot Stocks news story on Borqs Technologies »

Borqs Technologies Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$278.85

1.42 (0.51%)

, XLF

Financial Select Sector

$26.44

-0.07 (-0.26%)

13:41
02/22/19
02/22
13:41
02/22/19
13:41
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week, ETF fund…

SPY

SPDR S&P 500 ETF Trust

$278.85

1.42 (0.51%)

XLF

Financial Select Sector

$26.44

-0.07 (-0.26%)

XLB

S&P Select Materials SPDR

$55.79

0.25 (0.45%)

BSV

Vanguard Short-Term Bond Index Fund

$78.99

0.11 (0.14%)

BIV

Vanguard Intermediate-Term Bond ETF

$82.51

0.285 (0.35%)

BLV

Vanguard Long-Term Bond ETF

$89.00

0.685 (0.78%)

IEF

iShares 7-10 Year Treasury Bond ETF

$104.65

0.35 (0.34%)

QQQ

Invesco QQQ Trust

$172.67

1.06 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.16

2.09 (1.31%)

13:40
02/22/19
02/22
13:40
02/22/19
13:40
Periodicals
NY Governor asks for probe of Facebook use of personal info, Bloomberg says »

New York Governor Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

WEX

Wex

$176.23

5.88 (3.45%)

13:33
02/22/19
02/22
13:33
02/22/19
13:33
Earnings
Wex sees 2019 adjusted EPS $8.80-$9.20, consensus $8.94 »

Sees 2019 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

WEX

Wex

$176.23

5.88 (3.45%)

13:32
02/22/19
02/22
13:32
02/22/19
13:32
Earnings
Wex reported preliminary 2018 adjusted EPS $8.18, consensus $8.18 »

Reported preliminary 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

WEX

Wex

$176.24

5.89 (3.46%)

13:29
02/22/19
02/22
13:29
02/22/19
13:29
Hot Stocks
Wex delays earnings on up to $70M Brazilian subsidiary discrepancy »

Wex announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

WEX

Wex

$176.53

6.18 (3.63%)

13:26
02/22/19
02/22
13:26
02/22/19
13:26
Periodicals
Wex CEO tells Bloomberg business 'incredibly healthy' despite Brazil issue »

WEX's overall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

XRX

Xerox

13:20
02/22/19
02/22
13:20
02/22/19
13:20
Downgrade
Xerox rating change  »

Xerox downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$89.55

0.75 (0.84%)

13:20
02/22/19
02/22
13:20
02/22/19
13:20
Downgrade
United Continental rating change  »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.89

1.46 (0.53%)

13:20
02/22/19
02/22
13:20
02/22/19
13:20
Periodicals
U.S, China disusing late March summit between Xi and Trump, CNBC reports »

U.S. and China are…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.89

1.46 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$33.90

0.29 (0.86%)

13:20
02/22/19
02/22
13:20
02/22/19
13:20
Downgrade
Skechers rating change  »

Skechers downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

DXCM

DexCom

$139.14

-7.14 (-4.88%)

13:17
02/22/19
02/22
13:17
02/22/19
13:17
Hot Stocks
DexCom receives Health Canada approval for G6 CGM System »

Dexcom announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
02/22/19
02/22
13:17
02/22/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
02/22/19
02/22
13:16
02/22/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$19.90

0.33 (1.69%)

13:15
02/22/19
02/22
13:15
02/22/19
13:15
Options
Pure Storage put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 13

    Mar

13:15
02/22/19
02/22
13:15
02/22/19
13:15
General news
Breaking General news story  »

Philadelphia Federal…

13:15
02/22/19
02/22
13:15
02/22/19
13:15
General news
Breaking General news story  »

US Federal Reserve Bank…

13:15
02/22/19
02/22
13:15
02/22/19
13:15
General news
Breaking General news story  »

St. Louis Federal Reserve…

CGC

Canopy Growth

$44.32

-0.67 (-1.49%)

13:14
02/22/19
02/22
13:14
02/22/19
13:14
Hot Stocks
Canopy reverses decline after CEO talks asset possibilities with Bloomberg »

Shares of Canopy Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$26.29

0.01 (0.04%)

13:03
02/22/19
02/22
13:03
02/22/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 4 to 1,047 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 22

    May

  • 28

    May

EFX

Equifax

$110.23

-0.28 (-0.25%)

13:00
02/22/19
02/22
13:00
02/22/19
13:00
Hot Stocks
Equifax says U.S. regulators seek damages related to 2017 breach »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BILI

Bilibili

$19.48

1.34 (7.39%)

13:00
02/22/19
02/22
13:00
02/22/19
13:00
Options
Bullish option flow in Bilibili as shares rally 7% ahead of earnings »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

VALE

Vale

$12.45

0.43 (3.58%)

12:57
02/22/19
02/22
12:57
02/22/19
12:57
Periodicals
Federal prosecutors in Brazil seek arrest of senior Vale exec, Reuters reports »

Federal prosecutors in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$34.99

-13.2 (-27.39%)

, K

Kellogg

$56.53

-1.8 (-3.09%)

12:57
02/22/19
02/22
12:57
02/22/19
12:57
Periodicals
Prescience Point sees Kellogg following Kraft Heinz with dividend cut »

Short seller Prescience…

KHC

Kraft Heinz

$34.99

-13.2 (-27.39%)

K

Kellogg

$56.53

-1.8 (-3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

SNAP

Snap

$9.74

0.35 (3.73%)

12:50
02/22/19
02/22
12:50
02/22/19
12:50
Options
Snap calls active as shares see strength »

Snap calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.